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ABSTRACT 
In many instances the researcher cannot find an adequate or appropriate existing tool to measure an 
important construct- the theoretical variable that is supposed to measure. In these situations it will 
become necessary to develop a new instrument for measuring the particular construct. Failure to 
carefully develop a measurement instrument can result in invalid data. The steps involved in the 
development of such tools are complex and unknown to many. Hence, the systematic development of a 
reliable and valid instrument for measuring subjective states is outlined here to assist researchers in 
devising usable instruments.  
According to Ayurveda, the diseases are caused by derangement of Tridoshas- the dynamic force 
(Vatha), the transformation factor (Pitha) and the anabolic factor (Kapha). Avarana is the disturbances 
in the movement of Vathadosha by other factors in the body. In the present social scenario, majority of 
diseases of Vatha are the result of Avarana. Metabolic syndrome is one such lifestyle disease 
comprised of obesity, hyperglycemia, hypertension, hyper triglyceridemia and low HDL level. Majority 
of the symptoms of Avarana can be identified in patients presenting with Metabolic syndrome. This 
article outlines the methodology involved in the development and validation of a measurement tool, 
taking into consideration of Avarana in Metabolic Syndrome.  
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INTRODUCTION
In research studies different types of 
instruments are used: (i). standardized instruments, 
(ii). non-standardized instruments and(iii). instruments 
constructed by the researcher for the particular study. 
The standardized instruments have established 
reliability and validity. For the non-standardized but 
earlier used instruments, some estimate should be 
obtained for the reliability of every instrument 
constructed by the investigator. For validity, the logical 
estimates are often accepted without a statistical 
estimate. For the self constructed instrument, the 
researcher has to develop and validate the tool and 
must report: (a). the purpose for which it was 
constructed, (b). the different aspects and total number 
of statements under each aspect, (c). the nature of the 
statements, and (d). its reliability and validity 
coefficients[1]. The steps involved in the development 
and validation of such tools are difficult and unknown 
to many researchers. An overview of the tool 
development and validation are described in this article 
with special reference to Avarana in Metabolic 
syndrome. 
In Ayurveda, the three bioregulatory principles, 
the Thridoshas, the dynamic force (Vatha), the 
transformation factor (Pitha) and the anabolic factor 
(Kapha) are responsible for health and disease[2]. Of the 
three principles, Vatha is more important since it is the 
dynamic force and the vitiation of Vatha is occurring by 
the diminution of body tissues (Dhathukshaya) or 
occlusion of body channels (Avarana)[3]. According to 
Chakrapanidatta, in Avarana the vitiation of Vatha is the 
result of the obstruction to spontaneous stimulation for 
movement[4]. Metabolic syndrome is one of the major 
disorders where Avarana pathology can be observed 
since the etiology, symptomatology and pathogenesis 
can well be correlated. The etiology of Metabolic 
syndrome - affluence and lack of exercise are vitiating 
Kapha, Pitha and fatty tissue (Medodhathu) and they are 
obstructing the pathway of Vatha hindering its normal 
function leading to obesity (Athisthoulyam), 
hyperglycemia (Madhumeham), dyslipidaemia (Medo-
dosham) and hypertension (Vathakopam) which are the 
cardinal symptoms of metabolic syndrome[5]. Thus 
Avarana may be considered as the main pathogenic 
factor for the development of Metabolic syndrome. In 
the present social scenario, lifestyle diseases are 
becoming the major health hazards and metabolic 
syndrome is one such disorder. It is attaining epidemic 
status and is imparting intense burden to the society in 
terms of health hazards, expenditure for treatment and 
the reduction of productivity. Its chronicity and the 
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development of newer complications are challenging 
the effectiveness of Allopathic treatment. Ayurveda can 
put forward a superior management protocol for this 
chronic lifestyle disorder, by interpreting the condition 
of Metabolic syndrome with reference to the concept of 
Avarana. Since now, there is lack of an instrument for 
measuring Avarana in metabolic syndrome. The 
development of a simple tool with good reliability and 
validity to evaluate the presence of Avarana in 
Metabolic syndrome will help in the early screening of 
this disorder and formulation of better protocol for 
prevention and management.  
Steps in Development of Tool 
1. Conceptualization- Tool development process 
begins with forming a concept and refining it by 
giving a theoretical definition. In Ayurveda, a better 
understanding of Metabolic syndrome can be done 
by interpreting the condition with reference to the 
concept of Avarana. On exploring the concept, the 
etiological factors, pathophysiology and 
symptomatology of metabolic syndrome can very 
well be explained on the basis of Avarana. An 
operational tool may be developed for measuring 
Avarana in Metabolic syndrome with the 
symptomatology as the items of the tool. 
2. Item generation- Items in the proposed tool can be 
generated based on review of relevant literature, 
signs and symptoms, clinical experience, personal 
experience, and focus group discussion with 
respondent population and in-depth interviews 
with experts. This process will ensure the various 
dimensions of the concept and items to capture 
them. For developing a tool for Avarana in 
metabolic syndrome, items of the proposed tool can 
be generated by reviewing the signs and symptoms 
of Avarana explained in Charaka Samhitha, 
Susrutha Samhitha and Ashtanga Hridaya [3,6,7].The 
significance of the items in metabolic syndrome can 
be evaluated on the basis of signs and symptoms, on 
clinical experience, focus group discussion with 
subjects having metabolic syndrome and in-depth 
interviews with experts. These processes ensure the 
inclusion of various dimensions of the concept and 
appropriate items under specific domains. 
3. Item selection – Using Microsoft Office Access, 
overlapping items can be identified and deleted at 
first. The remaining symptoms can be grouped to 
make the interview with the respondent population 
easier. Items can then being selected by 
administering the draft tool among the patients 
with metabolic syndrome and selecting items with 
maximum discriminatory power. Expert paneling 
can be done by getting the feedback from at least 10 
experts, and to select the items most frequently 
endorsed by them.  
4. Item wording, sequencing and formatting- 
Selected items should be worded appropriately to 
suit the level of comprehension of the respondent 
population of patients with metabolic syndrome 
and sequenced from general to specific. The 
response format has to be structured and the 
number of response categories fixed, considering 
the understanding level of the respondent 
population.  
5. Scoring –The pattern of scoring has to be decided, 
usually giving equal weightage to all items if the 
number of items are more in the tool.  
6. Translation and back translation- The draft tool 
has then to be translated to local language and back-
translated to English to make sure that the meaning 
has not been altered on translation. This can be done 
by independent translators knowing the language as 
well as the content. 
7. Pre-testing by peer review, respondent review 
and expert review- The translated tool has to be 
given to peers and respondent population to test the 
wording and comprehensibility. Necessary 
modifications have to be made based on their 
feedback. Expert reviews should also be done to 
ensure the content coverage, clarity and simplicity of 
items in the tool.  
8. Pilot study-For the pilot study to measure Avarana 
in metabolic syndrome, the tool has to be 
administered in 10% of sample size, including 
patients having Metabolic Syndrome and those not 
having Metabolic Syndrome and mean score of each 
item can be calculated. Items with least 
discriminatory power can be deleted at this stage 
also. 
9. Reliability- Reliability refers to the repeatability, 
stability, and internal consistency of a tool. Before a 
tool can be used as a measure, it should be 
established that it measures “something” in a 
reproducible manner[8]. Repeatability of the tool will 
be assessed by test retest reliability and inter rater 
reliability. Test Retest reliability explains whether 
there is any difference in patient's status in two time 
points within 10-14 days, when assessed by the 
same examiner. To assess whether the different 
raters, assessing the same individual with the draft 
tool, can obtain similar scores, Inter Rater Reliability 
test is done. It is done by administering the draft tool 
by two raters on the same day and to find out 
whether they can obtain similar scores. It is 
measured with a coefficient between 0 and 1[9]. Test 
retest and inter rater reliability can be determined 
using intra class correlation coefficient (ICC) or 
kappa statistics depending upon nature of response 
categories. These tests can be conducted along with 
pilot study. Item wise intra class correlation can be 
calculated and any item with poor reliability can be 
modified and the process may be repeated. Internal 
consistency needs only single administration and can 
be determined after main study. 
10. Administration in sample population- The tool 
refined through the above processes has to be 
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administered among the sample population of 
patients having metabolic syndrome and those not 
having metabolic syndrome and the data can be 
collected. The sample size needs to be calculated in 
advance. A wide range of recommendations 
regarding sample size have been published in 
literature. These are usually stated in terms of 
subject to variable ratio. In clinical settings, for 
calculating the sample size for the main study, 
number of subjects selected for the study would be 5 
times the number of items in the tool.[10.11] 
11. Validity- Validity refers to whether one can draw 
accurate conclusions about the presence and degree 
of the attribute for an individual. In other words, 
validating a tool is a process by which we determine 
the degree of confidence we can place on the 
inferences, and we make about people based on 
their scores from that tool.[12] 
1. Face validity and Content validity - Face validity will 
be ensured during the early stages of development 
of tool itself by, content review by experts and 
respondent review. Content validity ensures that all 
aspects of the construct are represented by an 
adequate number of items and should not include 
items that are unrelated to the construct. 
2. Criterion validity -Criterion validity refers the 
correlation of new scale with an external criterion 
measuring the same construct which is supposed to 
be the gold standard.  
3. Construct validity- Construct validation is heavily 
relied upon in situations where there is no criterion 
with which a tool can be compared. One has to 
generate predictions based on the hypothetical 
construct (hypothesis generating) which are then 
tested to determine construct validity. It is an 
ongoing process of learning more about the 
construct, making new predictions, and testing 
them. Construct validity is determined statistically 
by factor analysis. 
12. Analysis 
Item analysis is the general term used to clean up the 
scales, item by item in order to maximize reliability 
and validity. The data obtained by administering the 
draft tool on sample population can be analyzed by 
the steps as follows.  
1. Descriptive statistics- Descriptive statistics help us to 
simplify large amount of data in a sensible way. They 
are used to describe the basic features of the data in 
a study. Both numerical and graphical summaries of 
distribution of each item should be obtained. Items 
which are highly skewed and do not show variability 
may be deleted. 
2. Inter item correlation, item total correlation and 
Cronbach’s 𝛼 (for assessing the internal consistency 
of the tool). For measuring a symptom, the scale 
must be homogenous, i.e., all of the item should be 
tapping different aspect of the same attribute and 
not different parts of different attributes. For a 
homogenous scale, the items should be moderately 
correlated with each other (inter item correlation) 
and each should correlate with the total scale score 
(item total correlation). An inter-item correlation 
matrix for each subscale should produce a matrix of 
positive correlations, ranging from modest values 
(0.2-0.4) to strong values (0.5-0.8). The item should 
correlate with the total subscale score above 0.20; 
items with lower correlations should be discarded. 
The internal consistency co-efficient (Cronbach’s 𝛼) 
tells about similarity in measurement across items 
within the subscale. Values for the 𝛼 coefficient 
ranges between 0.0-1.0; the 𝛼 coefficient will be 
larger (closer to 1) when the items are inter-
correlated. Cronbach’s 𝛼 of 0.80 is desirable and 0.70 
is acceptable (9). Cronbach’s 𝛼 may be calculated by 
eliminating one item at a time, by discarding any 
item one by one, where 𝛼 increases significantly. 
3. Exploratory factor analysis for item reduction and 
construct validity. Factor is an underlying dimension 
of several related variables. Factor analysis can be 
applied as an item reduction technique and as a test 
of construct validity. Kaiser-Mayor-Olkin (KMO) 
statistic (0.6 or more is acceptable) and Bartlett’s 
test for sphericity has to be done to check the 
sampling adequacy and factorisability of the data 
respectively. Construct validation can be done by 
exploratory factor analysis; extraction of factors 
done by principal component analysis and factor 
rotation, using varimax or promax depending on 
data, for better interpretation of factors. Eigen value 
is the amount of variance in the data explained by 
each factor. Usually the factors with Eigen value 
more than 1 will be retained. Item selection in factor 
analysis is based on factor loading, which is the 
correlation of the particular item with factor or 
domain. Minimum cut off for factor loading may be 
fixed as 0.35 or 0.4. Ideally the retained factors 
should account a cumulative variance of at least 
60%. Factor analysis will finally give the number of 
factors with appropriate items loaded under each 
domain and the maximum variance explained by all 
the factors in the tool.[12,13] 
13. Generation of final instrument after factor analysis- 
At the end of factor analysis an instrument with 
acceptable level of reliability and validity can be 
generated to measure Avarana in Metabolic 
syndrome. Additional measures of construct validity 
are i). convergent validity- reflects the overlap 
between alternative measures that tap the same 
construct ii). divergent validity- a valid tool should 
also fail to correlate with measures that tap different 
constructs. Discriminant validity is the ability of the 
tool to discriminate between different groups of 
participants and is quite often used interchangeably 
with divergent validity. Validation hypothesis is a 
series of hypothesis testing based on the tool will 
provide additional evidence for construct validity. 
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Criterion validity of the tool can be assessed by 
comparing with gold standard. Criterion validity of the 
Avarana tool can be assessed by comparing with 
metabolic syndrome. This method can be used for 
correctly identifying those individuals with Avarana 
among the subjects with metabolic syndrome 
(sensitivity) and the likelihood of correctly identifying 
people without Avarana among the subjects, not having 
metabolic syndrome (specificity). The receiver 
operating characteristic (ROC) curve analysis can 
explore the sensitivity (true positive) and specificity 
(true negative) of different cut-off points and area 
under the curve provides the measure of overall 
performance of the tool. By fixing arbitrary cutoff the 
tool can be used as a diagnostic tool of Avarana in 
Metabolic syndrome and to classify the subjects for 
different levels of management for Avarana in Metabolic 
syndrome.  
CONCLUSION  
A systematically developed and validated 
measurement tool is highly important in the field of 
research and clinical practice. The process for tool 
development and validation as explained above can 
ensure the quality of research to instill confidence in the 
results. Poor scale construction questions the reliability 
and validity of the research results, no matter how 
careful the study is designed. In contrast, carefully 
constructed measures help to advance the 
understanding and ensure that the study will provide 
accurate and usable data. The various steps outlined in 
the article would ensure the development of a reliable 
and valid tool with desirable level of psychometric 
properties. 
Metabolic syndrome is achieving epidemic 
status all over the world and complications like 
coronary artery disease are increasing the mortality. On 
compiling the symptoms of Avarana, majority of them 
can be identified in various conditions of metabolic 
syndrome. By following various steps explained in the 
article a scientific tool can be developed for measuring 
Avarana in metabolic syndrome. The development of 
such a tool to evaluate the presence of Avarana in 
Metabolic syndrome will help in the diagnosis or early 
screening of Metabolic syndrome and to allocate the 
patients for different levels of management.  
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